Researchers develop new antibody with potential to treat several types of cancer

Researchers at Uppsala University and KTH Royal Institute of Technology have developed a new form of precision medicine, an antibody, with the potential to treat several types of cancer.

What the Sandoz CEO is thinking about the 2024 elections

As Election Day 2024 gets closer, STAT’s First Opinion asked executives from leading biotech and pharmaceutical companies to reflect on how their industry is being

October 15, 2024

Immuno-oncology startup launches with $150 million, ex-Surface, Bluebird exec as CEO

Robert Ross had thought he would take more time off after his previous company, Surface Oncology, was acquired in September. The immuno-oncology firm had just

March 20, 2024

High caffeine consumption linked to changes in dopamine function in Parkinson’s patients

Regular high caffeine consumption affects dopamine function in patients with Parkinson’s disease, shows a new international study led by the University of Turku and Turku

May 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.